Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1415studies shown
Showing 385-396 of 1,415
Drug study icon
CompletedNCT00282464

Geodon for depression

This study is completed in the United States. It is testing geodon for depression.

Multiple locations, including Dothan
Bipolarity, DepressionDrugA study involving a medication or substance.Over 18 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00141271

Geodon for depression

This study is completed in the United States. It is testing geodon for depression.

Multiple locations, including Birmingham
Bipolarity, DepressionDrugOver 18 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00261443

Aripiprazole (Abilify) in people with Bipolar Mania

This study is completed in the United States, in France, in Brazil, .... It is testing aripiprazole (Abilify) for manic episodes in bipolarity.

Multiple locations, including Tuscaloosa
BipolarityDrugOver 18 Years
Countries
United States, France, Brazil, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity
Drug study icon
CompletedNCT05328297

JNJ-55308942 for depression in bipolarity

This study is completed in the United States, in Canada, in Poland, .... It is testing JNJ-55308942 for depression in bipolarity.

Multiple locations, including Huntsville
Bipolarity, DepressionDrugFrom 18 Years to 64 Years
Countries
United States, Canada, Poland, ...
Sponsor
Janssen Pharmaceutica N.V., Belgium
Condition
Bipolarity, Depression
Behavioral study icon
CompletedNCT05956340

Spoken Language in Mania

This study is completed in the United States. It is testing spoken Language for Bipolarity.

In Rochester
BipolarityBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Bipolarity
Drug study icon
CompletedNCT00650611

Safety study of ziprasidone in Schizophrenia

This study is completed in the United States. It is testing ziprasidone for Schizophrenia.

Multiple locations, including San Diego
Schizophrenia, BipolarityDrugFrom 10 Years to 17 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia, Bipolarity